(Q45062413)

9 December 2017

Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis (English)

1 reference

9 December 2017

1 reference

4

Hironobu Sasano

1 reference

9 December 2017

Tetsuhide Ito

1

1 reference

9 December 2017

Hisato Igarashi

2

1 reference

9 December 2017

Kazuhiko Nakamura

3

1 reference

9 December 2017

Takuji Okusaka

5

1 reference

9 December 2017

Koji Takano

6

1 reference

9 December 2017

Izumi Komoto

7

1 reference

9 December 2017

Masao Tanaka

8

1 reference

9 December 2017

Masayuki Imamura

9

1 reference

9 December 2017

Robert T Jensen

10

1 reference

9 December 2017

Ryoichi Takayanagi

11

1 reference

9 December 2017

Akira Shimatsu

12

1 reference

9 December 2017

6 February 2014

1 reference

Journal of Gastroenterology

9 December 2017

1 reference

9 December 2017

50

1 reference

9 December 2017

1

1 reference

9 December 2017

58-64

1 reference

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

9 December 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Gastroenteropancreatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

EUS elastography combined with the strain ratio of tissue elasticity for diagnosis of solid pancreatic masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Diagnosis and treatment of carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995-2012) in South China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Hereditary pancreatic endocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Endocrine tumours of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Everolimus for advanced pancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Recent standardization of treatment strategy for pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0934-2

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

21 January 2018

1 reference

12 December 2020

Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors

1 reference

12 December 2020

Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey

1 reference

12 December 2020

Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience

1 reference

12 December 2020

Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center

1 reference

12 December 2020

Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration

1 reference

12 December 2020

10.1007/S00535-014-0934-2

Identifiers

DOI

1 reference

9 December 2017

1 reference